4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000899243-18-018338
Director acquired 24,527 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Daniel Thomas O Director | 2018-06-25 | Conversion | +24,527 | 101,926 | D | ||
| Derivatives | |||||||
| Daniel Thomas O Director | 2018-06-25 | Conversion · Series A Preferred Stock | −33,350 | 0 | D | ||
| Daniel Thomas O Director | 2018-06-25 | Conversion · Series B Preferred Stock | −30,028 | 0 | D | ||
Loading xslF345X03/doc4.xml…